You have accessJournal of UrologyProstate Cancer: Basic Research1 Apr 2011618 IMMUNOHISTOCHEMISTRY FOR ERG EXPRESSION AS A SURROGATE FOR TMPRSS2-ERG FUSION DETECTION IN PROSTATIC ADENOCARCINOMA Alcides Chaux, Roula Albadine, Antoun Toubaji, Michael Haffner, Jessica Hicks, Alan Meeker, Angelo Demarzo, Elizabeth Platz, and George J. Netto Alcides ChauxAlcides Chaux Baltimore, MD More articles by this author , Roula AlbadineRoula Albadine Baltimore, MD More articles by this author , Antoun ToubajiAntoun Toubaji Baltimore, MD More articles by this author , Michael HaffnerMichael Haffner Baltimore, MD More articles by this author , Jessica HicksJessica Hicks Baltimore, MD More articles by this author , Alan MeekerAlan Meeker Baltimore, MD More articles by this author , Angelo DemarzoAngelo Demarzo Baltimore, MD More articles by this author , Elizabeth PlatzElizabeth Platz Baltimore, MD More articles by this author , and George J. NettoGeorge J. Netto Baltimore, MD More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2011.02.1471AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES We previously demonstrated the presence of TMPRSS2-ERG gene fusions in 46% of prostatic adenocarcinomas in a large cohort, using a break-apart fluorescence in situ hybridization (FISH) technique. In the current study, we assess expression of ERG fusion protein product using immumonhistochemistry (IHC) and correlate it with our previous FISH findings in the same cohort. METHODS The cohort consisted of 10 TMAs containing paired tumor and normal tissues from radical prostatectomies (RRP) performed at our hospital between 1993 and 2001. They included 441 cases. IHC was performed using a commercial rabbit anti-ERG monoclonal antibody (clone EPR 3864; Epitomics, Burlingame, CA), FISH analysis was previously performed using break-apart probes for 5' and 3' regions of ERG (Albadine, et al 2009). An IHC score (H score = intensity X percentage of positives cells) was assigned in each spot and averaged per tumor spots. When comparing fusion status by FISH and IHC techniques, any positive ERG expression on IHC was considered positive. Association strength was evaluated using the Fisher's exact test; classifier performances were calculated for IHC against FISH. RESULTS ERG overexpression was detected in 204 (46.3%) of all PCa and in none of the paired benign prostate samples while TMPRSS2-ERG fusion (either by split or deletion) were observed in 202 (45.8%) cases. There was a strong association between ERG IHC overexpression and TMPRSS2-ERG fusion status (P<0.00001); ERG IHC overexpression was detected in 87.1% of all cases with TMPRSS2-ERG fusion while 88.3% of cases with no TMPRSS2-ERG fusion were also ERG IHC negative. IHC for ERG overexpression had a sensitivity of 86% (95% CI 81–91%) and a specificity of 89% (95% CI 84–93%) in detecting TMPRSS2-ERG fusions. CONCLUSIONS We found a strong association between ERG IHC overexpression and TMPRSS2-ERG fusion detected by FISH. ERG IHC may offer an accurate, simpler and less costly alternative for evaluation of ERG fusion status in PCa. The significance and possible mechanisms of ERG overexpression in tumors with no TMPRSS2-ERG fusions merits further investigation. © 2011 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 185Issue 4SApril 2011Page: e249 Advertisement Copyright & Permissions© 2011 by American Urological Association Education and Research, Inc.MetricsAuthor Information Alcides Chaux Baltimore, MD More articles by this author Roula Albadine Baltimore, MD More articles by this author Antoun Toubaji Baltimore, MD More articles by this author Michael Haffner Baltimore, MD More articles by this author Jessica Hicks Baltimore, MD More articles by this author Alan Meeker Baltimore, MD More articles by this author Angelo Demarzo Baltimore, MD More articles by this author Elizabeth Platz Baltimore, MD More articles by this author George J. Netto Baltimore, MD More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
Read full abstract